ILiAD Biotechnologies SRL
14.4 FTEThe score of ILiAD Biotechnologies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -92 % Total assets -10 % Headcount (avg FTE) +109 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ILiAD Biotechnologies's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 04 Sep 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
ILiAD Biotechnologies's financial analysis
- Solvency2.4%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ILiAD Biotechnologies
ILiAD Biotechnologies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0741.579.648
- VAT number
- BE0741579648
- Peppol
- Registered · 0208:0741579648 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jan 2020
- Registered office
- 9052 Ghent
- Size
- Small · 14.4 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
ILiAD Biotechnologies (SRL) has been based in Ghent since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 76,960 € and equity of 25,626 €; its revenue is not published. With 14.4 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 2.4%, below the median of its sector (60.4%).
Companies similar to ILiAD Biotechnologies
Companies in the same business, of comparable size and area, outside its group.
- Blue3Berg Research and experimental development on natural sciences and engineering Zoersel · balance sheet 803,714 €
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- Rejuvenate Biomed Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet €3.45m
- Groovy.Bio Manufacture of pharmaceutical preparations Evergem · balance sheet 744,069 €
- Simabs Manufacture of pharmaceutical preparations Diepenbeek · balance sheet €2.67m
- MY Health International Manufacture of basic pharmaceutical products Lummen · balance sheet €1.04m
- Perjustinage Research and experimental development on natural sciences and engineering Péruwelz · balance sheet €1.17m
- 3.life Research and experimental development on natural sciences and engineering Ixelles · balance sheet 835,912 €
Frequently asked questions about ILiAD Biotechnologies
What is the revenue of ILiAD Biotechnologies?
ILiAD Biotechnologies files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ILiAD Biotechnologies?
In Belgium, the VAT number is the company number prefixed with BE: BE0741579648 for ILiAD Biotechnologies, if the company is VAT-registered. Its company number (CBE) is 0741.579.648.
Where is the registered office of ILiAD Biotechnologies?
According to the CBE register, the registered office of ILiAD Biotechnologies is in 9052 Ghent.
What is the equity of ILiAD Biotechnologies?
At the close of the 2025 financial year, the equity of ILiAD Biotechnologies amounts to 25,626 €, a solvency of 2.4% of total assets.
How many people work at ILiAD Biotechnologies?
14.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ILiAD Biotechnologies?
The register lists 5 active mandates at ILiAD Biotechnologies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ILiAD Biotechnologies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →